جست‌وجوی استاد و پژوهشگر

• Nutrition and Chronic Disease
• Cancer Epidemiology
• Obesity and Physical Activity
• +۳ مورد دیگر

Dagfinn Aune serves as a Research Fellow at the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine at Imperial College London. He concurrently holds positions as Associate Professor at Oslo New University College and Senior Researcher at the Cancer Registry of Norway in Oslo. His work centers on large-scale epidemiological investigations into diet, obesity, and chronic disease mechanisms across international populations. Education: PhD in Epidemiology, Norwegian University of Science and Technology (2016) MSc in Nutrition, University of Oslo (2008) Research interests focus on the interplay between dietary patterns, adiposity, physical activity, and smoking with chronic disease outcomes. His work examines how these factors influence cancer risk (particularly breast, gastrointestinal, and hematological malignancies), pregnancy complications, diabetes progression, and mortality across diverse populations. He employs systematic review methodologies and analyzes data from major cohorts including EPIC and Norwegian registries. Publication trends reveal consistent emphasis on obesity-cancer relationships, with recent work (2023-2025) expanding into metabolomic mediators, cardiometabolic interactions, and rare cancer epidemiology. His research frequently utilizes systematic reviews, meta-analyses, and multinational cohort studies to establish evidence for cancer prevention guidelines. Scientific Awards: No awards specified in source materials Advising and grant activity centers on major collaborative projects including the World Cancer Research Fund's Continuous Update Project, the EPIC study, and South American case-control research. While specific student mentorship isn't documented, his leadership in systematic review protocols suggests substantial training responsibilities. His grant portfolio includes funding from WCRF International and Norwegian research councils for large-scale epidemiological analyses. Labs and teams include the Centre for Translational Nutrition and Food Research at Imperial College London, where he collaborates with nutrition scientists and biostatisticians. He maintains active roles in the EPIC consortium and WCRF International's CUP Global Programme, coordinating multinational analyses of diet-cancer relationships through the Cancer Registry of Norway.

• Longitudinal Data Analysis
• Time-to-Event Analysis
• Survival Analysis
• +۵ مورد دیگر

Alessandra Meddis serves as an Assistant Professor in the Section of Biostatistics within the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic work centers on developing and applying advanced statistical methodologies for longitudinal and time-to-event data analysis, with significant contributions to public health research in Denmark and internationally. Her institutional affiliation is clearly established through university contact details and departmental listings. Her primary research interests include correlated survival data analysis, competing risk modeling, informative cluster size methodology, causal inference techniques for observational studies, and environmental epidemiology applications. Dr. Meddis has developed specialized expertise in handling complex survival data structures while maintaining focus on real-world public health problems, particularly in HIV comorbidity patterns, environmental exposure effects, and pandemic-related mortality analyses. Her methodological innovations directly address challenges in clustered and censored data common across medical research domains. Analysis of Dr. Meddis's recent publication record reveals a consistent trajectory of high-impact interdisciplinary research spanning clinical medicine, epidemiology, and statistical methodology. Her work appears in leading journals across biostatistics, infectious diseases, and public health, demonstrating strong collaborative networks with clinical researchers and epidemiologists. Key thematic areas include HIV treatment outcomes, environmental health exposures, and critical care applications during the pandemic, with recent methodological papers advancing survival analysis techniques for complex data structures. Scientific Awards: No scientific awards were specified in the available institutional profile. Advising and Grants: The institutional profile does not provide details regarding graduate student supervision or specific research grant funding. Her collaborative publications suggest involvement in multi-investigator projects including the COCOMO HIV cohort study and pandemic-related research initiatives. Labs and Teams: Dr. Meddis is affiliated with the Section of Biostatistics within the Department of Public Health, though specific laboratory facilities or dedicated research teams are not described in the source material. Her extensive co-authorship patterns indicate active participation in multiple research consortia across medical specialties.

Megan Rennaمشاهده پروفایل

استادیار

• Clinical Psychology
• Clinical Health Psychology
• Emotion Regulation
• +۶ مورد دیگر

Dr. Megan Renna is an Assistant Professor in Clinical Psychology at the University of Southern Mississippi. She earned her Ph.D. in Clinical Psychology from Columbia University's Teachers College and completed a postdoctoral fellowship funded by the National Cancer Institute at Ohio State University Comprehensive Cancer Center. Her research focuses on the bidirectional relationship between psychological and physical health, particularly how emotion regulation and negative emotionality contribute to chronic disease risk in breast cancer survivors and healthy adults. Education: Ph.D. in Clinical Psychology (2019) and M.Ph. (2018) from Teachers College, Columbia University Training: Predoctoral internship at Duke University Medical Center Her work bridges clinical psychology, psychophysiology, and behavioral medicine through studies on inflammation, autonomic dysfunction, and cancer survivorship. Recent publications examine metabolic syndrome, smartwatch body composition metrics, and couples' health dynamics. Key research themes include stress reactivity, emotion regulation therapy, and biobehavioral pathways linking mental states to physiological outcomes. Dr. Renna teaches Advanced Psychopathology and can be reached at Megan.Renna@usm.edu. Her methodological expertise spans experimental worry inductions, longitudinal studies, and psychometric scale development, with a focus on reducing distress disorders through emotion regulation interventions.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Cardiovascular Research
• Hypertension
• Pharmacology
• +۵ مورد دیگر

Nancy J. Brown, M.D., is the Jean and David W. Wallace Dean of the Yale School of Medicine and holds the C.N.H. Long Professorship in Internal Medicine. Previously, she served as Chair of Vanderbilt Department of Medicine and Physician-in-Chief of Vanderbilt University Medical Center (2010–2020). Her academic career spans over three decades, with leadership roles in clinical care, research, and medical education. Education: MD, Harvard University (1986) AB in Molecular Biophysics and Biochemistry, Yale College (1981) Internship and Residency in Medicine, Vanderbilt University (1989) Fellowship in Clinical Pharmacology, Vanderbilt University (1991) Chief Resident, Vanderbilt University (1992) Research Interests: Dr. Brown’s work focuses on the renin-angiotensin-aldosterone system’s role in cardiovascular disease, hypertension, and thrombosis. Her lab has elucidated mechanisms linking aldosterone, bradykinin, and ACE inhibitors to inflammation, fibrosis, and cardiovascular risk. Current studies explore neprilysin inhibitors in heart failure and incretin-based therapies’ cardiovascular effects. Key Contributions: Identified genetic variants and African ancestry as risk factors for ACE inhibitor-associated angioedema Developed Vanderbilt’s Master of Science in Clinical Investigation program (2000) Advocated for physician-scientist development through leadership roles in NIH councils and professional organizations Recognition: Recipient of the Harriet Dustan Award, August M. Watanabe Prize, and Robert H. Williams Distinguished Chair of Medicine. Elected to the National Academy of Medicine and American Academy of Arts & Sciences. Labs/Teams: Leads the Yale School of Medicine’s cardiovascular research initiatives, focusing on translational studies of RAAS pathways and drug mechanisms.

Maciej A Mazurowskiمشاهده پروفایل

دانشیار

• Medical Imaging
• Machine Learning
• Computer Vision
• +۳ مورد دیگر

Maciej A Mazurowski is an Associate Professor at Duke University School of Medicine, with dual appointments in the Department of Biostatistics & Bioinformatics and Radiology. He is also affiliated with the Department of Electrical and Computer Engineering and is a member of the Duke Cancer Institute. His research focuses on applying machine learning to medical imaging for improved diagnosis and treatment. Ph.D. in Computer Science from the University of Louisville (2008) Dr. Mazurowski's research emphasizes medical imaging , machine learning , and computer vision applications in radiology. His work includes automated segmentation , domain adaptation , prognostic modeling , and foundation models for MRI/CT analysis. His recent publications highlight trends in universal segmentation models (SegmentAnyBone, SegmentAnyMuscle), foundation models for MRI (MRI-CORE), and AI-driven diagnostic tools for breast cancer, glioblastoma, and thyroid nodules. Key challenges addressed include domain generalization , image harmonization , and ethical considerations in clinical AI. Incubation Award for innovative research commercialization Dr. Mazurowski has secured significant research funding from agencies including the National Institutes of Health , National Institute of Biomedical Imaging and Bioengineering , and American Roentgen Ray Society . His work spans CT segmentation , MRI analysis , and AI-based quality assessment across multiple imaging modalities.

• Physical Activity Epidemiology
• Public Health
• Cardiometabolic Health
• +۴ مورد دیگر

Emmanuel Stamatakis is a Professor of Physical Activity, Lifestyle, and Population Health at the University of Sydney's School of Health Sciences (Faculty of Medicine and Health). He holds NHMRC Leadership Fellowships (2021-2025 and 2026-2030) and leads the Charles Perkins Centre's Physical Activity & Exercise Theme. His research focuses on lifestyle behaviors' impacts on cardiometabolic conditions, cancer, and cardiovascular health, using large-scale cohort studies and wearable device data. Key roles include directing the Mackenzie Wearables Research Hub and co-chairing WHO's Physical Activity Guidelines Development Group. Education: PhD from University of Bristol (2003), post-doctoral training at University College London. He leads the ProPASS consortium, involving 45 cohorts with wearable data. Over 460 peer-reviewed publications, including Clarivate's Highly Cited list since 2019. Research interests integrate physical activity, sedentary behavior, and sleep analytics with clinical outcomes. Current projects explore wearables-based measurement innovations, SPAN (sleep-physical activity-nutrition) synergies, and intervention designs for GLP-1 receptor agonist users. Recent articles emphasize VILPA (vigorous intermittent lifestyle physical activity) benefits, sleep-cardiovascular links, and multimodal lifestyle optimization. Awards include Australia's Top Researcher in Sports Medicine and multiple NHMRC grants. Supervises PhD projects on physical activity measurement and intervention design. Active in 50+ peer-reviewed journals and national/international funding bodies.

Paula Ravascoمشاهده پروفایل

دانشیار

• Nutrition
• Clinical Nutrition
• Oncology
• +۵ مورد دیگر

Paula Ravasco is an Associate Professor at the Católica Medical School , Catholic University of Portugal , and a Researcher at the Center for Interdisciplinary Research in Health (CIIS) . She is a Medical Doctor specializing in Immuno-haematology and Haemotherapy, a Nutritionist with expertise in Clinical Nutrition, and holds a PhD in 'Cancer: metabolic dysfunction, nutrition and Quality of Life'. International postgraduate studies in clinical nutrition, research methodologies, and immunity-nutrition interactions Coordinator of international advanced training programs in Nutrition, Metabolism, and Cancer Faculty member of the European Society for Clinical Nutrition and Metabolism (ESPEN) Her research focuses on nutritional interventions in oncology, with emphasis on vitamin D supplementation , sarcopenia in cancer patients , and synbiotics in colorectal cancer treatment . Recent work includes systematic reviews on nutritional biomarkers, patient outcomes, and quality of life improvements through noninvasive monitoring. Key projects include NutriCancerMonitor for multidimensional nutritional monitoring during cancer treatment and the Vulneráveis mais vulneráveis initiative addressing inflammatory risk in homeless populations during the COVID-19 pandemic. Her collaborations span national and international institutions, with a focus on nutrition-oncology intersections , geriatric nutritional care , and systematic review methodologies . She contributes to UN Sustainable Development Goals (SDGs) through educational programs and nutritional research.

Sara Häggمشاهده پروفایل

مدرس ارشد

• Epidemiology
• Gerontology
• Medical Genetics and Genomics
• +۳ مورد دیگر

Sara Hägg is a Senior Lecturer at the Karolinska Institutet , affiliated with the Department of Medical Epidemiology and Biostatistics . She is also a Docent in molecular epidemiology. PhD in Computational Biology (Linköping University, 2009) MSc in Molecular Biology (Stockholm University, 2003) BSc in Computer Science (Stockholm University, 2003) Her research focuses on human biological aging , including measurement of aging markers (telomere length, epigenetic clocks, frailty index), causal pathway analysis, and identification of geroprotectors for age-related diseases. She utilizes longitudinal twin studies (SATSA, GENDER, HARMONY), UK Biobank, and Swedish cohorts with methods like Mendelian randomization and genome-wide analyses . Recent articles demonstrate trends in epidemiological aging research , with emphasis on cardiovascular aging , neurological disease interactions , metabolic profiling , and epigenetic clocks . Her work often involves multivariable modeling and cross-cohort validation . Leadership roles include Director of LifeGene Core Facility (2024-) and Founding Board Member of the Nordic Aging Society (2023-). She serves on expert groups for the Swedish Twin Registry and Strategic Research Area in Epidemiology and Biostatistics .

• Cancer Genetics
• Prostate Cancer
• Genomic Evolution
• +۵ مورد دیگر

Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health. Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications. 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine) 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy) 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis) In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.

Anne Berit C. Samuelsenمشاهده پروفایل

دانشیار

• Polysaccharide Chemistry
• Pharmacognosy
• Carbohydrate Polymers
• +۴ مورد دیگر

Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.

Stanley J. Rogersمشاهده پروفایل

استاد

• Minimally Invasive Surgery
• Bariatric Surgery
• Laparoscopic Surgery
• +۷ مورد دیگر

Dr. Stanley J. Rogers is a Professor in the Department of Surgery at the University of California, San Francisco (UCSF), School of Medicine. He holds the Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery and the His Majesty King Bhumibol Adulyadej, Rama IX Distinguished Professorship of Global Surgery. He serves as Interim Division Chief of General Surgery and directs the Bariatric Surgery Center, Liver Tumor Ablation Program, and Minimally Invasive Surgery Program. He is also a staff and trauma surgeon at Zuckerberg San Francisco General Hospital and Trauma Center, where he leads videoendoscopic surgery. University: University of California, San Francisco School: School of Medicine Department: Department of Surgery Role: Professor, Interim Division Chief, Director Email: stan.rogers@ucsf.edu Dr. Rogers' research and clinical expertise focus on minimally invasive and bariatric surgical techniques, particularly laparoscopic surgery, sleeve gastrectomy, gastric bypass, and liver tumor ablation. His work explores the metabolic and skeletal consequences of bariatric procedures, with a strong emphasis on calcium metabolism, bone health, and gut microbiome changes. He has contributed extensively to understanding complications and outcomes in gastrointestinal and metabolic surgery. His recent publications show a consistent trend in studying the long-term metabolic and skeletal impacts of bariatric surgery, particularly comparing sleeve gastrectomy and gastric bypass. Key themes include bone mineral density changes, calcium absorption, hormonal regulation (e.g., PYY), and the role of the gut microbiome. Many studies involve collaborations with endocrinologists and metabolic researchers, reflecting a multidisciplinary approach to surgical outcomes. Scientific Awards and Honors: Honorary Fellow, Royal College of Surgeons (2016) His Majesty King Bhumibol Adulyadej Rama IX Distinguished Professor of Global Surgery, UCSF (2012) Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery, UCSF (2011) Fellow, American College of Surgeons (1995) Dr. Rogers has supervised numerous residents and fellows and is actively involved in clinical training. He has served as Principal Investigator and Co-Investigator on multiple NIH-funded grants, including studies on calcium absorption, sleeve gastrectomy effects, and anti-reflux surgery. His work has significant implications for improving postoperative care and long-term outcomes in bariatric patients. He is affiliated with several key programs at UCSF, including the Bariatric Surgery Center, the Liver Tumor Ablation Program, the Minimally Invasive Surgery Program, the Comprehensive Cancer Center, and the Institute for Global Health Sciences. His leadership extends to clinical trials on endoscopic techniques and bariatric revision surgery.

James Turnerمشاهده پروفایل

دانشیار

• Exercise Immunology
• Cancer Immunology
• Ageing and Immunosenescence
• +۳ مورد دیگر

James Turner is an Associate Professor in Exercise Physiology and Immunology at the University of Birmingham's School of Sport, Exercise and Rehabilitation Sciences. Previously, he held roles at the University of Bath as a Lecturer (Assistant Professor) from 2013 to 2018 and promoted to Senior Lecturer (Associate Professor) in 2018 before moving to Birmingham in 2022. His research focuses on lifestyle impacts on ageing and chronic disease, particularly adipose tissue immunology and cancer immunology (e.g., breast cancer). He leads projects examining obesity, immune system ageing, and factors influencing cancer treatment outcomes. His work aligns with UN Sustainable Development Goals related to health and well-being. Education: BSc (Hons) Sport and Exercise Science (University of Bath, 2006); PhD in Exercise Biochemistry and Immunology (University of Birmingham, 2011). Post-doctoral training in cancer immunology followed. He has mentored 9 PhD/MSc students as lead or co-supervisor and contributed to grants from bodies like Cancer Research UK and the Biotechnology and Biological Sciences Research Council. Current research includes projects on adipose tissue inflammation and muscle mass regulation in older adults. Labs/Teams: Active in collaborative projects with institutions globally, focusing on exercise immunology and cancer treatment efficacy. Editor for journals like Frontiers in Physiology and International Journal of Sport Nutrition and Exercise Metabolism .

TANIA FERNÁNDEZ VILLAمشاهده پروفایل

دانشیار

• Preventive Medicine
• Public Health
• Nutritional Epidemiology
• +۵ مورد دیگر

Tania Fernández Villa is an Associate Professor in the Department of Biomedical Sciences at the Faculty of Veterinary Medicine, University of León. Her primary academic affiliation centers on preventive medicine and public health research within the GIIGAS (Interactions Gene-Environment-Health) research group. Her research spans nutritional epidemiology, gender studies in food systems, substance use disorders, and chronic disease prevention. Key focus areas include alcohol consumption patterns among university students (via the UniHcos cohort), sarcopenia in metabolic syndrome, breast cancer risk factors, and pandemic impacts on health behaviors. Her work integrates longitudinal cohort analysis, systematic reviews, and psychometric validation studies. Recent publications demonstrate strong trends in gender-disaggregated health research, pandemic-related behavioral shifts, and methodological innovations in dietary assessment. Her 2024-2025 output shows increasing emphasis on environmental sustainability of diets and multi-cancer risk prediction models. She serves on the editorial board of the Spanish Journal of Human Nutrition and Dietetics, contributing to strategic planning (2020-2026) and open science initiatives. Her PhD from Universidad de Granada focused on ICT usage patterns among university students. Current projects include the UniHcos longitudinal study tracking health behaviors in Spanish university students, with particular attention to alcohol use, sleep patterns, and nutritional status. Her research group actively investigates gene-environment interactions in public health contexts.

• Environmental Epidemiology
• Children's Environmental Health
• Molecular Epidemiology
• +۳ مورد دیگر

Margaret Karagas, PhD is the inaugural Department Chair and James W. Squires Professor of Epidemiology at the Geisel School of Medicine at Dartmouth College, with a secondary appointment as Professor of Community and Family Medicine. She also serves as Director of both the Children's Environmental Health and Disease Prevention Research Center and the Center for Molecular Epidemiology at Dartmouth. Her leadership extends to the NIH-funded Environmental Influences on Child Health Outcomes (ECHO) Program, which encompasses over 90,000 participants across the United States. Dr. Karagas earned her PhD from the University of Washington in 1990 and has established herself as a leading researcher in environmental epidemiology. She collaboratively developed an innovative cross-disciplinary postdoctoral and graduate program in Quantitative Biomedical Sciences (QBS) that integrates epidemiology, bioinformatics, and bistatistics. Her research focuses on interdisciplinary studies investigating environmental exposures, host factors, and biological mechanisms affecting health from infancy through adulthood, with particular emphasis on under-studied rural populations. Dr. Karagas employs high-dimensional analytic tools along with biomarkers and sensors to study the exposome, genetic susceptibility, and biological response. Her work has uncovered adverse cardiometabolic, neurodevelopmental, and immune-related health outcomes associated with drinking water contaminants, food-borne toxicants (including in infant first foods), and exposures from woodstoves. Analysis of her recent publications reveals a strong focus on environmental health impacts across the lifespan, with significant contributions to understanding how environmental exposures affect child development, chronic disease risk, and health disparities. Her work frequently employs advanced molecular and analytical techniques to assess environmental exposures and their biological consequences. Dr. Karagas serves on numerous prestigious international consensus panels and committees, including those for the United Nations, World Health Organization, International Agency for Research on Cancer, European Food Safety Authority, US National Institutes of Health, and National Academies of Science, Engineering and Medicine. As an academic leader, she has mentored diverse investigators at all career stages and established innovative training programs. Her research has directly contributed to practice and policy changes regarding environmental health threats. She maintains active collaborations across multiple centers at Dartmouth including the Dartmouth Toxic Metals Superfund Research Program and Dartmouth SYNERGY.